Vascular Graft Platform

About Aruga Technologies

Aruga Technologies is a private, early-stage biotech firm leveraging AI and machine learning to engineer next-generation vascular grafts and shunts. The company's technology is designed to replicate the biological and mechanical properties of natural arteries, with a primary goal of preventing device failure due to thrombosis, a major limitation of current synthetic grafts. Operating in the high-need vascular surgery market, Aruga appears to be in a pre-clinical or early R&D stage, positioning itself to address significant unmet clinical needs in hemodialysis access and peripheral vascular disease. As a pre-revenue company, its success will depend on successful technology validation, regulatory progress, and securing further development funding.

About Aruga Technologies

Aruga Technologies is a private, early-stage biotech firm leveraging AI and machine learning to engineer next-generation vascular grafts and shunts. The company's technology is designed to replicate the biological and mechanical properties of natural arteries, with a primary goal of preventing device failure due to thrombosis, a major limitation of current synthetic grafts. Operating in the high-need vascular surgery market, Aruga appears to be in a pre-clinical or early R&D stage, positioning itself to address significant unmet clinical needs in hemodialysis access and peripheral vascular disease. As a pre-revenue company, its success will depend on successful technology validation, regulatory progress, and securing further development funding.

Therapeutic Areas